1. Metabolism of lisofylline and pentoxifylline in human liver microsomes and cytosol;Lillibridge;Drug Metab. Dispos.,1996
2. Lisofylline causes rapid and prolonged suppression of serum levels of free fatty acids;Bursten;J. Pharmacol. Exp. Ther.,1998
3. CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes;Shin;J. Pharm. Sci.,1998
4. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid;Rice;Proc. Natl. Acad. Sci. USA,1994
5. Potential role for phosphatidic acid in mediating the inflammatory responses to TNF α and IL-1β;Bursten;Circ. Shock,1994